alexa Israel Vlodavsky
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Israel Vlodavsky

Professor,Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel 
Biography

 Professor Israel Vlodavsky, ICA-financed researcher, was born (August 1944) in Haifa, Israel. He received his B.Sc and M.Sc. degrees from the Hebrew University of Jerusalem and his Ph.D. from the Wiezmann Institute. Following postdoctoral training at UCLA and UCSF, he attained an academic position at the Sharett Oncology Institute of the Hadassah-Hebrew University Medical Center, where he established the Tumor Biology Research Unit.
He then served as a visiting professor at Harvard and the Memorial Sloan-Kettering Cancer Center. From 2002 until today, he has been heading (under a joint agreement with Hadassah) the Cancer & Vascular Biology Research Center of the Rappaport Faculty of Medicine at the Technion.
Professor Vlodavsky's long-term research in the area of cancer metastasis led to the cloning of a human gene encoding an enzyme (heparanase) that degrades an abundant polysaccharide constituent (heparan sulfate) of the vessel wall and extracellular matrix.

 

Clearly, the research team headed by Vlodavsky is the pioneering and world leading group in this area of research. Enhanced heparanase expression was found to be causally associated with the metastatic potential of cancer cells, tumor angiogenesis and reduced postoperative survival of cancer patients. These observations indicate heparanase as a promising target for a rational design of inhibitory compounds and antibodies that enhance early detection and treatment of cancer patients.

In fact, the research team headed by Professor Vlodavsky has already developed heparanase-inhibiting compounds and strategies. One of these compounds is highly effective in experimental models of myeloma and will enter a clinical trial in 2009. Professor Vlodavsky has supervised 24 students to a Ph.D. degree. The results of his long term research were published in more than 350 scientific papers and presented (plenary lectures) in over 130 international conferences.

 

Professor Vlodavsky is regarded as a pioneer in the area of cell interaction with the extracellular matrix and the significance of the tumor microenvironment in cancer progression.

 

In recognition of his scientific achievements, Israel was awarded prestigious awards (e.g., Elkeles, Teva, Taub, Landau) and his research is supported by the National Institutes of Health (NIH). Professor Vlodavsky is a research professor of the Israel Cancer Research Fund (ICRF), and a member of international and national scientific committees and granting agencies.     

Research Interest

 Enzymes, Tumor Biology, Vascular Biology,Empyema

Publications

Involvement of Heparanase in Empyema: Implication for Novel Therapeutic Approaches

Moshe Lapidot, Uri Barash, Yaniv Zohar, Yuval Geffen, Inna Naroditsky, Neta Ilan, Lael Anson Best and Israel Vlodavsky

Research Article: J Clin Cell Immunol 2015, 6: 290

DOI: 10.4172/2155-9899.1000290

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords